Glial proteins such as glial fibrillary acidic protein (GFAP), and S100β, which are both structural astrocytic proteins, are two very promising blood biomarkers that could be indicative of stroke in patients presenting with symptoms of acute neurological dysfunction. This evidence concerns the gene GFAP and Stroke.